Cargando…

Metformin Improves Overall Survival of Colorectal Cancer Patients with Diabetes: A Meta-Analysis

Introduction. Diabetic population has a higher risk of colorectal cancer (CRC) incidence and mortality than nondiabetics. The role of metformin in CRC prognosis is still controversial. The meta-analysis aims to investigate whether metformin improves the survival of diabetic CRC patients. Methods. Pu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Meng, Fanqiang, Song, Li, Wang, Wenyue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2017
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320297/ https://www.ncbi.nlm.nih.gov/pubmed/28271076 http://dx.doi.org/10.1155/2017/5063239

Ejemplares similares

Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis
por: Ma, Shu-Juan, et al.
Publicado: (2016)

Improved Overall Survival of Colorectal Cancer under Multidisciplinary Team: A Meta-Analysis
por: Peng, Dong, et al.
Publicado: (2021)

Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
por: Mei, Zu-Bing, et al.
Publicado: (2014)

Correction: Survival Benefits of Metformin for Colorectal Cancer Patients with Diabetes: A Systematic Review and Meta-Analysis
Publicado: (2014)

The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis
por: Tian, Shan, et al.
Publicado: (2017)

Reduced Risk of Colorectal Cancer With Metformin Therapy in Patients With Type 2 Diabetes: A meta-analysis
por: Zhang, Zhi-Jiang, et al.
Publicado: (2011)

The role of EZH2 in overall survival of colorectal cancer: a meta-analysis
por: Vilorio-Marqués, Laura, et al.
Publicado: (2017)

Metformin therapy and the risk of colorectal adenoma in patients with type 2 diabetes: A meta-analysis
por: Hou, Yi-Chao, et al.
Publicado: (2016)

Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis
por: Liu, Feifei, et al.
Publicado: (2016)

Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis
por: Tang, Yun-Liang, et al.
Publicado: (2017)

GLIM‐defined malnutrition and overall survival in cancer patients: A meta‐analysis
por: Yin, Liangyu, et al.
Publicado: (2022)

Metformin Is Associated With Slightly Reduced Risk of Colorectal Cancer and Moderate Survival Benefits in Diabetes Mellitus: A Meta-Analysis
por: He, Xing-kang, et al.
Publicado: (2016)

The effect of metformin on the survival of colorectal cancer patients with type 2 diabetes mellitus
por: Tarhini, Zeinab, et al.
Publicado: (2022)

Metastatic colorectal cancer-prolonging overall survival with targeted therapies
por: Dattatreya, Satya
Publicado: (2013)

Impact of Physical Activity on Cancer-Specific and Overall Survival of Patients with Colorectal Cancer
por: Des Guetz, Gaetan, et al.
Publicado: (2013)

The impact of metformin use on survival in kidney cancer patients with diabetes: a meta-analysis
por: Li, Yang, et al.
Publicado: (2017)

Survival advantage observed with the use of metformin in patients with type II diabetes and colorectal cancer
por: Garrett, C R, et al.
Publicado: (2012)

Physical Activity Is Associated with Improved Overall Survival among Patients with Metastatic Colorectal Cancer
por: Smit, Karel C., et al.
Publicado: (2022)

Metformin and Colorectal Cancer Risk in Diabetic Patients
por: Ioannou, George N., et al.
Publicado: (2011)

Are metformin, statin and aspirin use still associated with overall mortality among colorectal cancer patients with diabetes if adjusted for one another?
por: Zanders, M M J, et al.
Publicado: (2015)

Colorectal and Prostate Cancer Risk in Diabetes: Metformin, an Actor behind the Scene
por: Anwar, M. Akhtar, et al.
Publicado: (2014)

Superoxide dismutases in relation to the overall survival of colorectal cancer patients.
por: Janssen, A. M., et al.
Publicado: (1998)

Drug Holidays and Overall Survival of Patients with Metastatic Colorectal Cancer
por: Garattini, Silvio Ken, et al.
Publicado: (2021)

Epithelial-Mesenchymal Transition Phenotype, Metformin, and Survival for Colorectal Cancer Patients with Diabetes Mellitus II
por: Wang, Yaodu, et al.
Publicado: (2017)

Metformin Treatment for Diabetes Mellitus Correlates with Progression and Survival in Colorectal Carcinoma
por: Powell, Marta K., et al.
Publicado: (2019)

Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysis
por: Lu, Yifan, et al.
Publicado: (2022)

CD30(+)OX40(+) Treg is associated with improved overall survival in colorectal cancer
por: Lam, Jian Hang, et al.
Publicado: (2021)

High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer
por: Berry, Ryan S., et al.
Publicado: (2017)

The effect of metformin on survival of patients with pancreatic cancer: a meta-analysis
por: Li, Xiaogang, et al.
Publicado: (2017)

Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis
por: Zhou, Ping-Ting, et al.
Publicado: (2017)

Sarcopenia reduces overall survival in unresectable oesophageal cancer: a systematic review and meta‐analysis
por: Jogiat, Uzair M., et al.
Publicado: (2022)

Subsequent anti-VEGF therapy after first-line anti-EGFR therapy improved overall survival of patients with metastatic colorectal cancer
por: Qiu, Tianzhu, et al.
Publicado: (2018)

Tumor Control and Overall Survival after Stereotactic Body Radiotherapy for Pulmonary Oligometastases from Colorectal Cancer: A Meta-Analysis
por: Choi, Hoon Sik, et al.
Publicado: (2020)

Validation of the Survival Benefits of Metformin in Middle Eastern Patients With Type II Diabetes Mellitus and Colorectal Cancer
por: Al Omari, Amal, et al.
Publicado: (2018)

The impact of metformin on survival in diabetes patients with operable colorectal cancer: A nationwide retrospective cohort study
por: Chu, Ping-Teng, et al.
Publicado: (2023)

Nomogram for predicting overall survival in colorectal cancer with distant metastasis
por: Liu, Zheng, et al.
Publicado: (2021)

Telomerase is an independent prognostic marker of overall survival in patients with colorectal cancer
por: Bertorelle, R, et al.
Publicado: (2013)

Prediction of overall survival following colorectal cancer surgery in elderly patients
por: Seow-En, Isaac, et al.
Publicado: (2019)

The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta-Analysis
por: Yao, Xiangyang, et al.
Publicado: (2021)

Impact of local treatment on overall survival of patients with metastatic prostate cancer: systematic review and meta-analysis
por: Carneiro, Arie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_p5k0uenqvpf0l0ekhr0vp85a6b